Operating Expenses 更改
AstraZeneca USD 9.54B 578M 2023-09
Biogen USD 2.03B 344.1M 2023-12
Genmab DKK 3.03B 326M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
GRIFOLS EUR 1.35B 73.17M 2023-09
Hikma Pharmaceutical USD 1.18B 60M 2023-06
Incyte USD 826.07M 121.75M 2023-12
Merck EUR 4.19B 143M 2023-09
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Roche Holding CHF 20.02B 5.04B 2023-06
UCB EUR 2.11B 388M 2023-06
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Galapagos 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.